Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia

Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

(2011) Alison G. Freifeld et al.   CLINICAL INFECTIOUS DISEASES

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli

(2010) Cheol-In Kang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia

(2010) Cheol-In Kang et al.   JOURNAL OF INFECTION

Bloodstream Infections and Clinical Significance of Healthcare-associated Bacteremia: A Multicenter Surveillance Study in Korean Hospitals

(2010) Jun Seong Son et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Factors associated with mortality in bacteremic patients with hematologic malignancies

(2009) Mario Tumbarello et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia

(2009) C.-Y. CHEN et al.   EPIDEMIOLOGY AND INFECTION

Bacteraemia due to extended-spectrum  -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome

(2009) C. Gudiol et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical Significance and Predictors of Community-Onset Pseudomonas aeruginosa Bacteremia

(2008) Hae Suk Cheong et al.   AMERICAN JOURNAL OF MEDICINE